Goldman Sachs’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.5M Buy
1,290,138
+547,464
+74% +$2.76M ﹤0.01% 2595
2025
Q1
$4.81M Buy
742,674
+225,544
+44% +$1.46M ﹤0.01% 2778
2024
Q4
$3.8M Sell
517,130
-315,553
-38% -$2.32M ﹤0.01% 3064
2024
Q3
$6.24M Buy
832,683
+49,884
+6% +$374K ﹤0.01% 2604
2024
Q2
$6.97M Sell
782,799
-119,543
-13% -$1.06M ﹤0.01% 2383
2024
Q1
$9.14M Buy
902,342
+324,585
+56% +$3.29M ﹤0.01% 2114
2023
Q4
$5.81M Buy
577,757
+175,543
+44% +$1.77M ﹤0.01% 2489
2023
Q3
$3.77M Sell
402,214
-85,688
-18% -$803K ﹤0.01% 2678
2023
Q2
$12M Buy
487,902
+92,095
+23% +$2.26M ﹤0.01% 1895
2023
Q1
$9.21M Sell
395,807
-221,350
-36% -$5.15M ﹤0.01% 2076
2022
Q4
$15.6M Sell
617,157
-71,625
-10% -$1.81M ﹤0.01% 1798
2022
Q3
$13.3M Buy
688,782
+219,702
+47% +$4.24M ﹤0.01% 1920
2022
Q2
$11.9M Sell
469,080
-148,670
-24% -$3.79M ﹤0.01% 1983
2022
Q1
$15.9M Buy
617,750
+60,368
+11% +$1.55M ﹤0.01% 1884
2021
Q4
$23.3M Sell
557,382
-58,713
-10% -$2.46M ﹤0.01% 1648
2021
Q3
$26.8M Buy
616,095
+96,649
+19% +$4.21M 0.01% 1508
2021
Q2
$24.6M Sell
519,446
-479,696
-48% -$22.7M 0.01% 1580
2021
Q1
$51.2M Buy
999,142
+446,909
+81% +$22.9M 0.01% 1022
2020
Q4
$14.8M Buy
552,233
+146,862
+36% +$3.93M ﹤0.01% 1783
2020
Q3
$13.9M Buy
405,371
+324,934
+404% +$11.2M ﹤0.01% 1724
2020
Q2
$3.3M Buy
80,437
+26,672
+50% +$1.09M ﹤0.01% 2569
2020
Q1
$1.84M Buy
53,765
+40,232
+297% +$1.38M ﹤0.01% 2806
2019
Q4
$170K Buy
+13,533
New +$170K ﹤0.01% 4023